SB 129 DE

0likes☆Favorite🔕SubscribeShare

Became Law

Senate Bill 166, passed in 2022, created the Prescription Opioid Impact Fund as part of an overall structure that would both maximize the monies paid by settling Opioids defendants to Delaware and to create a structure whereby those settlement monies could be managed and distributed on a statewide basis through a stakeholder-informed process. The complete legislation is found at Title 16 of the Delaware Code, Chapter 48B, Sections 4801B through 4809B. Chapter 48B applied to settlements with entities, and did not apply to bankruptcies. This is because the bankruptcy process itself extinguishes claims and thus provides the necessary “global peace” for settling parties. At the time SB 166 was passed, it was contemplated that, in the context of the Purdue Pharma bankruptcy, the Sackler family members would obtain this type of bankruptcy-style discharge and release. However, in the summer of 2024, the United States Supreme Court ruled that such a discharge was impermissible. This decision thus required that the states negotiate a non-bankruptcy settlement with the Sacklers, which the Delaware Department has since been pursuing diligently. As announced on January 23, 2025, the Delaware Department of Justice has reached a proposed settlement-in-principle with Purdue Pharma and the Sackler family. In order to once again maximize the amount of Sackler money that Delaware will receive, it is now necessary to update the statutory bar created by the SB 166 to account for the fact that the Sackler family members are “individuals” not “entities." Consequently, the Delaware Department of Justice is recommending the amendments to Chapter 48B of Title 16 reflected in this Act.

• Stephanie L. Hansen Democratic · primary
• Ray Seigfried Democratic · primary
• Claire Snyder-Hall Democratic · primary
• David P. Sokola Democratic · primary
• Bryan Townsend Democratic · primary
• Sarah McBride · primary
• Russell Huxtable Democratic · primary
• Spiros Mantzavinos Democratic · primary

1. May 7, 2025 Introduced and Assigned to Health & Social Services Committee in Senate · upper
2. May 14, 2025 Reported Out of Committee (Health & Social Services) in Senate with 8 Favorable · upper
3. May 20, 2025 Passed By Senate. Votes: 19 YES 2 ABSENT · upper
4. May 21, 2025 Assigned to Health & Human Development Committee in House · lower
5. Jun 11, 2025 Reported Out of Committee (Health & Human Development) in House with 5 Favorable, 5 On Its Merits · lower
6. Jun 25, 2025 Passed By House. Votes: 39 YES 1 ABSENT 1 VACANT · lower
7. Jul 21, 2025 Signed by Governor · executive